TA215 Pazopanib for the first-line treatment of renal cell carcinoma: Appendix B - proposal paper presented to the Institute's Guidance Executive
![]() |
TA215 Pazopanib for the first-line treatment of renal cell carcinoma: Appendix B - proposal paper presented to the Institute's Guidance Executive
09 September 2013 (286.52 Kb 23 sec) |
This page was last updated: 09 September 2013